Additional Metadata
Keywords 177Lu-DOTATATE, 90Y-DOTATOC, COVID-19, Infectious Disease, Lymphopenia, Neuroendocrine, PRRT, Radionuclide Therapy
Persistent URL dx.doi.org/10.2967/jnumed.120.249136, hdl.handle.net/1765/128222
Journal Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Citation
Bodei, L, Bergsland, E.K. (Emily K.), de Herder, W.K. (Wouter K.), Ferone, D, Hicks, R.J. (Rodney J.), Hope, T.A. (Thomas A.), … Herrmann, K. (Ken). (2020). Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. doi:10.2967/jnumed.120.249136